GAMMA Investing LLC grew its holdings in DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 311.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 803 shares of the company’s stock after purchasing an additional 608 shares during the period. GAMMA Investing LLC’s holdings in DocuSign were worth $72,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in the stock. Itau Unibanco Holding S.A. purchased a new stake in shares of DocuSign in the third quarter worth about $28,000. Brooklyn Investment Group bought a new position in shares of DocuSign in the third quarter worth $33,000. Reston Wealth Management LLC bought a new position in DocuSign in the 3rd quarter worth about $47,000. Wilmington Savings Fund Society FSB purchased a new stake in shares of DocuSign in the 3rd quarter valued at about $51,000. Finally, Quarry LP purchased a new position in shares of DocuSign during the second quarter worth about $53,000. Hedge funds and other institutional investors own 77.64% of the company’s stock.
DocuSign Stock Up 1.0 %
Shares of DocuSign stock opened at $90.42 on Friday. The business has a 50 day moving average of $87.19 and a 200 day moving average of $68.97. DocuSign, Inc. has a 52 week low of $48.70 and a 52 week high of $107.86. The company has a market cap of $18.27 billion, a PE ratio of 18.64, a P/E/G ratio of 8.70 and a beta of 0.92.
Insiders Place Their Bets
Analysts Set New Price Targets
Several equities research analysts have issued reports on the stock. Morgan Stanley lifted their target price on shares of DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a research report on Friday, December 6th. Citigroup boosted their price target on shares of DocuSign from $87.00 to $113.00 and gave the stock a “buy” rating in a research note on Friday, December 6th. Jefferies Financial Group raised their price objective on DocuSign from $80.00 to $95.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. JPMorgan Chase & Co. increased their target price on DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a report on Tuesday, December 3rd. Finally, Piper Sandler raised their price target on DocuSign from $60.00 to $90.00 and gave the stock a “neutral” rating in a research report on Friday, December 6th. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, DocuSign currently has a consensus rating of “Hold” and a consensus price target of $92.45.
Check Out Our Latest Research Report on DOCU
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories
- Five stocks we like better than DocuSign
- Stock Splits, Do They Really Impact Investors?
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- Are Penny Stocks a Good Fit for Your Portfolio?
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.